News

Leukogene Therapeutics Inc. (LTI), a biopharmaceutical company focused on developing next-generation immunotherapies for blood and solid cancers, announced that the U.S. Food and Drug…
Read More...

Pacira BioSciences, Inc. has announced an exclusive worldwide license and collaboration agreement with AmacaThera to develop and commercialize AMT-143, a novel long-acting formulation…
Read More...

Merck, known as MSD outside the U.S. and Canada, has entered into a $700 million funding agreement with Blackstone Life Sciences to support the development of sacituzumab tirumotecan…
Read More...

Avant Technologies Inc., a Nevada-based corporation, and Singapore-based biotechnology firm SGAustria Pte. Ltd. have announced a Joint Venture and License Agreement to pioneer…
Read More...

Cencora, a leading global pharmaceutical solutions company, has announced plans to invest $1 billion through 2030 to strengthen and expand its pharmaceutical distribution network across…
Read More...

Eli Lilly and Company has announced plans to invest $3 billion in a new state-of-the-art manufacturing facility in Katwijk, the Netherlands, located within the Leiden Bio Science Park.…
Read More...

UCB, a global biopharmaceutical company, has received U.S. Food and Drug Administration (FDA) approval for KYGEVVI, a treatment for adults and pediatric patients suffering from…
Read More...

IntoCell Inc., a biotechnology company specializing in next-generation payload and linker technologies for antibody–drug conjugates (ADCs), has entered into a strategic collaboration…
Read More...

Helex, a biotechnology company developing targeted therapies for genetic kidney diseases, has announced the completion of an oversubscribed $3.5 million Seed round led by pi Ventures,…
Read More...

Dewpoint Therapeutics, a biotechnology company pioneering condensate biology, announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to…
Read More...

Eli Lilly and Company announced plans to invest over $1.2 billion to expand and modernize its Lilly del Caribe manufacturing site in Carolina, Puerto Rico, strengthening its U.S.…
Read More...

Novo Nordisk has confirmed submitting an unsolicited proposal to acquire U.S.-based Metsera, Inc., a biotechnology company developing early- and mid-stage incretin and non-incretin…
Read More...

Swiss biopharmaceutical company Debiopharm has entered into a strategic research collaboration with South Korea–based biotech firm NetTargets to accelerate the discovery of novel,…
Read More...

Seres Therapeutics, Inc. announced that CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator) has awarded the company up to $3.6 million in additional…
Read More...

The U.S. Food and Drug Administration (FDA) has unveiled a new draft guidance aimed at making the development of biosimilar medicines—lower-cost alternatives to expensive biologic…
Read More...

Alexion, AstraZeneca Rare Disease, announced that the European Commission has approved Koselugo (selumetinib) for the treatment of symptomatic, inoperable plexiform neurofibromas (PN)…
Read More...

Kazia Therapeutics Limited announced plans to hold a follow-up Type C meeting with the U.S. Food and Drug Administration (FDA) to discuss new overall survival (OS) findings from…
Read More...

Novartis announced that it has successfully completed the acquisition of Tourmaline Bio, Inc., making the biotechnology company an indirect wholly owned subsidiary of Novartis.…
Read More...

Guardant Health, a leader in precision oncology, has announced a strategic partnership with Zephyr AI, a precision medicine company specializing in artificial intelligence, to…
Read More...

Merck, known as MSD outside the United States and Canada, announced that the U.S. Food and Drug Administration (FDA) has expanded the approval of WINREVAIR™ (sotatercept-csrk) for the…
Read More...